Handbook of Clinical medicine

all of the following: Or 3 out of 5 of the following: • Prothrombin time (PT) >100s 1 Drug-induced liver failure • Creatinine >300μmol/L 2 Age< 10 or >40yrs old • Grade III or IV encephalopathy. 3 >1wk from 1st jaundice to encephalopathy 4 PT >50s 5 Bilirubin≥ 300μmol/L. Fulfi lling these criteria predicts poor outcome in acute liver failure and should prompt consideration for transplantation (p277). Reproduced from O'Grady J et al. ‘Early indicators of prognosis in fulminant hepatic failure.’ Gastroenterology, 97(2):439–45, 1989 with permission from Elsevier. __OOHHCCMM__1100ee..iinnddbb 227755 0022//0055//22001177 1199::0077 ygoloretneortsaG 276 Cirrhosis Cirrhosis (Greek kirrhos = yellow) implies irreversible liver damage. Histologically, there is loss of normal hepatic architecture with bridging fi brosis and nodular regeneration. Causes Most often chronic alcohol abuse, HBV, or HCV infection. Others: see BOX ‘Causes of cirrhosis’. Signs Leuconychia: white nails with lunulae undemarcated, from hypo- albuminaemia; Terry’s nails—white proximally but distal ⅓ reddened by telangi- ectasias; clubbing; palmar erythema; hyperdynamic cir culation; Dupuytren’s contracture; spider naevi (fi g 6.27); xanthelasma; gynaecomastia; atrophic testes; loss of body hair; parotid enlargement (alcohol); hepatomegaly, or small liver in late disease; ascites; splenomegaly. Complications Hepatic failure: Coagulopathy (failure of hepatic synthesis of clotting factors); encephalopathy
